JamesTaylorVIMD
Hematology • Washington, DCSickle Cell & Other Anemias
Director, Center for Sickle Cell Disease, Howard University ; Professor of Medicine and Microbiology, Howard University College of Medicine
Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2041 Georgia Ave NW
Washington, DC 20060Phone+1 612-625-1110Fax+1 202-865-5018
Summary
- Dr. James Taylor specializes in Hematology in Washington, DC and is affiliated with Howard University Hospital. Since 2017, he has served as the Director of the Howard University Center for Sickle Cell Disease. He is a Professor of Medicine (Hematology/Oncology) and Microbiology at Howard University College of Medicine; and also an Adjunct Professor in Food and Nutrition Sciences at the University of Manitoba, Winnipeg, Canada. He received his medical degree from Medical College of Wisconsin and has been in practice 22 years. He specializes in sickle cell & other anemias and is experienced in pulmonary hypertension, sickle-cell anemia, general internal medicine, clinical research, and genetic analysis. He is also a faculty member for training MS and PhD students.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1995 - 1998
Medical College of WisconsinClass of 1995
Certifications & Licensure
MD State Medical License 2001 - 2025
DC State Medical License 2016 - 2024
MO State Medical License 1997 - 2022
MN State Medical License 2016 - 2018- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- John Benjamin Nichols Award Medical Society of the District of Columbia, 2023
- Humanitarian Award Queens Sickle Cell Action Network (QSCAN)/SCDAA, 2019
Clinical Trials
- Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia Start of enrollment: 2008 Feb 19
- Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria Start of enrollment: 2006 Jun 15
- Genetics and Pain Severity in Sickle Cell Disease Start of enrollment: 2012 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- 133 citationsHemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin SAarti Agarwal, Aldiouma Guindo, Yacouba Cissoko, James G. Taylor, Drissa Coulibaly
Blood. 2000-10-01 - 12 citationsPatterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell disease.James G. Taylor Vi, Delia Tang, Charles B. Foster, Graham R. Serjeant, Griffin P. Rodgers
American Journal of Hematology. 2002-02-01 - 81 citationsVariants in the VCAM1 gene and risk for symptomatic stroke in sickle cell diseaseJames G. Taylor Vi, Delia C. Tang, Sharon A. Savage, Susan F. Leitman, Seth I. Heller
Blood. 2002-12-15
Press Mentions
Cures for Sickle Cell Disease Arrive After a Painful JourneySeptember 17th, 2024
Hematologists consider where new therapies fit in sickle cell treatment paradigmDecember 19th, 2023
Top DC doctor reacts to new sickle cell treatmentDecember 15th, 2023- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- French
External Links
- ORCIDhttps://orcid.org/0000-0002-4421-1809
- Scopus profilehttps://www.scopus.com/authid/detail.uri?authorId=7405408594
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
